The store will not work correctly when cookies are disabled.
(E)-3-(4-hydroxy-3-methoxyphenyl)-1-(5-isopropylpyrazin-2-yl)prop-2-en-1-one
ID: ALA2288836
PubChem CID: 76323910
Max Phase: Preclinical
Molecular Formula: C17H18N2O3
Molecular Weight: 298.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(/C=C/C(=O)c2cnc(C(C)C)cn2)ccc1O
Standard InChI: InChI=1S/C17H18N2O3/c1-11(2)13-9-19-14(10-18-13)15(20)6-4-12-5-7-16(21)17(8-12)22-3/h4-11,21H,1-3H3/b6-4+
Standard InChI Key: PLIJYQYRUQERLT-GQCTYLIASA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
9.7347 -1.9810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7336 -2.8006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4416 -3.2095 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1513 -2.8001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1484 -1.9774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4398 -1.5722 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8546 -1.5662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5639 -1.9721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8515 -0.7490 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.2700 -1.5608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9793 -1.9668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9792 -2.7828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6877 -3.1887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3948 -2.7774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3891 -1.9560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6801 -1.5538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0938 -1.5422 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8045 -1.9456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1046 -3.1823 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0255 -3.2086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3182 -2.7994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0249 -4.0258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
15 17 1 0
17 18 1 0
14 19 1 0
2 20 1 0
20 21 1 0
20 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 298.34 | Molecular Weight (Monoisotopic): 298.1317 | AlogP: 3.21 | #Rotatable Bonds: 5 |
Polar Surface Area: 72.31 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.50 | CX Basic pKa: ┄ | CX LogP: 2.75 | CX LogD: 2.75 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.68 | Np Likeness Score: 0.22 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |